Mislocalization of p27 from the nucleus to the cytoplasm is generally associated with poor prognosis and survival, high tumor grade and metastasis [13, 18–22], suggesting a potential application of cytoplasmic p27 as a clinical prognostic marker. This evidence concerns the gene CDKN1B and neoplasm.